Enemeez Kids docusate sodium 100 mg/5mL Liquid — NDC 17433-9886-6 (Billing 17433-9886-06)
This is a package of Enemeez Kids docusate sodium 100 mg/5mL Liquid from Quest Products LLC, marketed since Jan 2023 and currently FDA-listed.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 075657
- GCN: 40745
- GPI-14 (Medi-Span): 46500010305103
- HICL (First Databank): 001326
- AHFS class code: 56:12.00.00
- RxCUI (RxNorm): 1486983
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Softeners, emollients class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Enemeez Kids is a rectal liquid product containing docusate sodium, an over-the-counter stool softener marketed under FDA's OTC monograph rules for this drug category. Docusate sodium is typically used to soften stool and ease bowel movements. This formulation is designed for pediatric use and is administered as a rectal solution.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Docusate Sodium — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 3, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 17433-9886-05 17433-9886-5 Main listing | 5 TUBE in 1 BOX / 5 mL in 1 TUBE | 2023-01-03 | — | Active |
| 17433-9886-06 You're viewing this | 6 TUBE in 1 CONTAINER / 5 mL in 1 TUBE | 2023-09-14 | — | Active |
| 17433-9886-02 17433-9886-2 | 2 TUBE in 1 CONTAINER / 5 mL in 1 TUBE | 2024-01-26 | — | Active |
Pack size FAQ
What quantity is in this package?
What NDC number is used to bill for this package of Enemeez Kids docusate sodium 100 mg/5mL Liquid?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Enemeez Kids 100 mg/5mLthis 17433-9886-06 | Quest | 6 tubes | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses For relief of occasional constipation (irregularity). This product generally produces a bowel movement in 2 to 15 minutes.
⏱️ Dosage and Administration ▾
Directions Children 2 years to under 12 years of age (with adult supervision) one unit daily. Children under 2 years of age, consult a doctor prior to use. Twist off and remove tip.
Lubricate tip prior to insertion: Place a few drops of the tube's liquid content on the shaft prior to insertion. Also apply liquid content or lubricant to the anus before inserting the mini-enema. Positioning: For best results, lay on the left side with knees bent.
Alternate Positions: Administer while seated on the toilet. Or, kneel, then lower head and chest forward until side of face is resting on the surface. With steady pressure, gently insert the tube into the rectum with care to prevent damage to the rectal wall.
Insert up to shoulder of tube. Squeeze to empty the contents. Keep the tube squeezed until it is removed from the rectum.
After the contents have been emptied, remove the disposable tube and discard. A small amount of liquid may remain in the unit after use.
⚠️ Warnings ▾
Warnings For rectal use only. Drug Interaction Precaution: Do not take this product if you are presently taking mineral oil, unless directed by a doctor.
🧪 Active Ingredient ▾
Drug Facts Active Ingredient (per delivered dose) Docusate Sodium USP 100 mg
🧪 Inactive Ingredients ▾
Inactive Ingredients Glycerin USP and Polyethylene Glycol
🎯 Purpose ▾
Purpose Stool Softener Laxative
📄 Do Not Use ▾
Do not use Laxative products when abdominal pain, nausea or vomiting are present. Laxative products for a period longer than 1 week unless directed by a doctor.
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if you have: Rectal bleeding. Noticed a sudden change in bowel habits that persists over a period of 2 weeks. Failed to have a bowel movement after use. This may indicate a serious condition.
🤰 If Pregnant or Breast-Feeding ▾
Pregnant or Lactating Women Ask a health professional before use.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.
📄 Other Information ▾
Other Information Store at room temperature 15° - 30° C (59° - 86° F)
📄 Package Label / Principal Display Panel ▾
5 count Package PDP
Medicaid utilization by pack size
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |